Semler Scientific (OTCMKTS:SMLR) Upgraded to “Hold” by ValuEngine
SMLR stock traded up $0.05 during mid-day trading on Friday, reaching $43.55. The company had a trading volume of 2,974 shares, compared to its average volume of 17,264. The company has a market capitalization of $283.96 million, a price-to-earnings ratio of 65.98, a price-to-earnings-growth ratio of 1.55 and a beta of 0.38. The firm has a fifty day simple moving average of $41.79 and a 200 day simple moving average of $44.38. Semler Scientific has a fifty-two week low of $25.50 and a fifty-two week high of $54.50.
Semler Scientific (OTCMKTS:SMLR) last posted its quarterly earnings results on Friday, July 26th. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.10. Semler Scientific had a return on equity of 155.19% and a net margin of 27.91%. The company had revenue of $7.95 million for the quarter, compared to analyst estimates of $6.72 million. Sell-side analysts predict that Semler Scientific will post 1.13 EPS for the current year.
Semler Scientific Company Profile
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Story: Margin
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.